Description
SC-514 is an orally active, ATP-competitive IKK-2 inhibitor with IC50 of 3-12 µM, blocks NF-κB-dependent gene expression, does not inhibit other IKK isoforms or other serine-threonine and tyrosine kinases.A selective and reversible inhibitor of IKKβ (IKK-2)